Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test

Planta Medica

Volumn 66, Issue 1, 2000, Pages 3-6

  Butterweck, Veronika ^a   Jürgenliemk, Guido ^a   Nahrstedt, Adolf ^a   Winterhoff, Hilke ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ASTILBIN; FLAVONOID; HYPERICUM PERFORATUM EXTRACT; HYPERIN; IMIPRAMINE; ISOQUERCITRIN; MIQUELIANIN; QUERCITRIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; FORCED SWIMMING TEST; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; FLAVONOIDS; HYPERICUM; MALE; MOTOR ACTIVITY; PLANTS, MEDICINAL; RATS; SWIMMING;

ANIMALIA; HYPERICUM PERFORATUM;

EID: 0033963119     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11119     Document Type: Article

References (13)

1. 1 Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum. Pharmacopsychiatry 1997; 30 (Suppl): 129-134
2. 2 Butterweck V, Wall A, Lieflaender-Wulf U, Winterhoff H, Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry 1997; 30 (Suppl): 117-124
3. 3 Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the Forced Swimming Test. Planta Medica 1998; 64: 291-294
4. 4 Bhattacharya SK, Chakrabarti A, Chatterjee SS. Activity profiles of two hyperforin-containing Hypericum extracts in behavioural models. Pharmacopsychiatry 1998; 31 (Suppl): 22-29
5. 5 Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Müller WE. Hyperforin as a possible antidepressant compound of Hypericum extracts. Life Sciences 1998; 63: 499-510
6. 6 Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977; 266: 730-732
7. 7 Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments. European Journal of Pharmacology 1978, 47: 379-391
8. 8 Vogel GH, Vogel WH. Drug Discovery and Evaluation. Springer, Berlin Heidelberg 1997;: 206-207
9. 9 Sparenberg B, Demisch L, Hoelzl J. Untersuchungen über antidepressive Wirkstoffe von Johanniskraut. Pharmazeutische Zeitung Wissenschaft 1993; 6 (138): 50-54
10. 10 Thiede HM, Walper A. Inhibition of MAO and COMT by Hypericum extracts and hypericin. Journal of Geriatric Psychiatry and Neurology 1994; 7 (Suppl. 1): 54-56
11. 11 Baureithel KH, Büter KB, Engesser A, Burkard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum. Pharmaceutica Acta Helvetiae 1997; 72: 153-157
12. 12 Simmen U, Schweitzer C, Burkard W, Schaffner W, Lundstrom K. Hypericum perforatum inhibits the binding of μ and κ opiod receptor expressed with the Semliki Forest virus system. Pharmaceutica Acta Helvetiae 1998; 73: 53-56
13. 13 Ito Y, Conway W. Development of countercurrent chromatography. Analytical Chemistry 1984; 56: 534-554